Concepedia

Mary Lou Affronti

ML

Statistics

Publications

27

Citations

1.4K

H-Index

21

Active since

1990

Affiliations

Duke Medical Center(Current)

Duke University

Duke University Hospital

Duke University Health System

Pediatric Brain Tumor Foundation

Mary Lou Affronti is an author at Duke Medical Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1990–2024

27

Publications

27

Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma

Jennifer A. Quinn, David A. Reardon, Allan H. Friedman et al. · Journal of Clinical Oncology · 2003 · 254 citations

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

Mary Lou Affronti, Christopher R. Heery, James E. Herndon et al. · Cancer · 2009 · 136 citations

2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

Jørn Herrstedt, Rebecca Clark-Snow, Christina H. Ruhlmann et al. · ESMO Open · 2024 · 114 citations · Full text

Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas.

Daniela A. Bota, Annick Desjardins, Jennifer A. Quinn et al. · PubMed · 2007 · 97 citations · Full text

, , +18

4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial.

Elizabeth J. Shpall, Roy B. Jones, Robert C. Bast et al. · Journal of Clinical Oncology · 1991 · 89 citations

, , +18

1–5 of 27